Recent advances and the near-term outlook for Advanced Therapy Medicinal Products in cancer treatment
Abstract
The field of oncology has seen significant medicinal advances in recent years, with advanced therapy medicinal products (ATMPs) bringing new promise to the treatment of cancers. Research continues to explore next-generation cell and gene therapies, offering novel and often curative ways to tackle many different cancers and cancer subtypes.
This article assesses some of the most notable clinical developments in recent years, where the next generation of research is likely to be heading in the coming years, how the regulatory authorities are responding to these advances, and how these developments and regulatory proposals are likely to impact patient access.
How to read this journal article
Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to TOPRA members and registered users.
If you are a TOPRA member, or have already registered for limited free access, log in now (Option 1 below).
Not yet a member? You can either join TOPRA (Option 2 below) or register to view limited content for free (Option 3 below).
The Organisation for Professionals in Regulatory Affairs
- Contact us
- Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved